Pathway link PDCD4-MTORC2
PDCD4 mTORC2
PDCD4 inhibits mTORC2.
PDCD4 grabs Rictor and keeps mTORC2 from working.
The conditions it holds under
Human NSCLC cell lines and mouse xenografts; not shown in normal tissue. Single study.
- Time it takes
- minutes
- Step
- direct (one molecule acts on the other)
- Measured in
- human cells, mouse
- Where in the cell
- cytosol
- Reaches people?
- plausible in people, not shown directly
- How settled
- emerging, few independent studies
Studies behind it
| Year | Evidence | Study |
|---|---|---|
| 2026 | M | Pdcd4-Rictor interaction suppresses mTORC2-PFKFB3 axis and tumorigenesis in NSCLC.WANG2026B Pdcd4 binds Rictor via residues R105/K108/R110 to disrupt mTORC2 assembly and kinase activity, lowering PFKFB3 levels and suppressing glycolysis and NSCLC tumour growth. |
Points the other way
No study in the Atlas contradicts this link. That means none in this curated set, not none in the literature.
Who has checked this
- Checked by
- No researcher outside the project has checked this link yet.
- Curator sign-off
- Not signed off yet. This link was drafted with AI help and has not been reviewed link by link; treat it as a proposal until it is.
- Curated by
- Oliver Barton, with AI help for drafting; see how links are checked.
← The whole pathway · This link as JSON
Was this page useful?
Thank you. Your answer was counted anonymously.
Spotted something wrong or out of date about this link?
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.